Overview

Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PKs) of ZYDPLA1 Following Oral Administration in Healthy Volunteers

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This First in Human (FIH) Phase I study intends to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of ZYDPLA1 in normal healthy adult volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Cadila Healthcare Limited